Skip to main content

TCR2 Therapeutics Inc.

TCRRDelisted Jun 1, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001750019

TCR2 Therapeutics Inc. was delisted on Jun 1, 2023; its insiders filed their last Form 4 on Feb 14, 2024; 59 institutions reported holding it in 13F filings for Q1 2023, worth $31.5M in total; no superinvestor held it.

13F holders, Q2 2022

Institutional positions in TCR2 Therapeutics Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
83
−9 vs. Q1 2022
Shares held
24.9M
−2.19M (−8.1%) vs. Q1 2022
Total value
$72.2M
−$2.51M (−3.4%) vs. Q1 2022
New holders
14
11 more added
Sold out
23
37 more reduced

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TCRR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 83 institutions
Q1 2021: 129 institutionsQ2 2021: 119 institutionsQ3 2021: 117 institutionsQ4 2021: 122 institutionsQ1 2022: 94 institutionsQ2 2022: 83 institutionsQ3 2022: 81 institutionsQ4 2022: 63 institutionsQ1 2023: 59 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2022: $72.2M
Q1 2021: $834.8MQ2 2021: $575.3MQ3 2021: $271.1MQ4 2021: $136.0MQ1 2022: $74.8MQ2 2022: $72.2MQ3 2022: $45.1MQ4 2022: $21.2MQ1 2023: $31.5MQ2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding TCRR and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 202359$31.5M
Q4 202263$21.2M
Q3 202281$45.1M
Q2 202283$72.2M
Q1 202294$74.8M
Q4 2021122$136.0M
Q3 2021117$271.1M
Q2 2021119$575.3M
Q1 2021129$834.8M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding TCR2 Therapeutics Inc.; share changes are against Q1 2022.

Institutions holding TCRR in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Simplex Trading, LLC0$00.00%−2,280−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−2,276−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−1,000−100.0%Sold out
Plante Moran Financial Advisors, LLC0$00.00%−900−100.0%Sold out
Quantbot Technologies LP0$00.00%−800−100.0%Sold out
Prospera Financial Services Inc0$00.00%−100−100.0%Sold out
Parametric Portfolio Associates LLC––––Not filed
Amalgamated Financial Corp.––––Not filed